DAVOS: Novozymes Can Settle Investors’ Stomachs
Enzymes producer Novozymes (NVZMY) gave investors indigestion last year, but its prospects look more palatable in 2013. Investors have been reassured by the Danish company’s disclosure of 2012 earnings earlier this month. The numbers showed that profitability increased even though organic sales came in at the bottom end of expectations. Novozymes produces industrial enzymes, microorganisms [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here